Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

Coherus BioSciences Inc CHRS Pharmaceuticals Healthcare Deals and Alliances Profile Updated 23022017 Prices from USD $250

$
0
0
SummaryCoherus BioSciences Inc Coherus BioSciences focuses on the development and commercialization of biosimilar drugs. Its pipeline portfolio includes candidates such as CHS1701 is a pegfilgrastim used to treat febrile neutropenia CHS0214 is an etanerce...

Viewing all articles
Browse latest Browse all 2985

Trending Articles